levocabastine (Compound)

Synonyms:levocabastine, 79516-68-0, Levocabastinum [Latin], Levocabastina [Spanish], Cabastine [INN], Cabastine, (3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid, 79449-98-2, Levocabastin, Levocabastine (INN), COU3RRH769, (3S,4R)-1-(4-Cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenylpiperidine-4-carboxylic acid, H68BP06S81, Levocabastina, Levocabastinum, LEVOCABASTINE [INN], Levocabastine [INN:BAN], Cabastinum, R-50547, UNII-COU3RRH769, Levocobastine, UNII-H68BP06S81, Prestwick0_001039, Prestwick1_001039, Prestwick2_001039, Prestwick3_001039, LEVOCABASTINE [MI], SCHEMBL4577, R 50547, BSPBio_001257, LEVOCABASTINE [VANDF], SCHEMBL152978, SPBio_003108, LEVOCABASTINE [WHO-DD], BPBio1_001382, GTPL1586, CHEMBL1615438, DTXSID1048548, CHEBI:92584, CHEBI:135679, DTXSID001024637, BDBM50019405, AKOS016013998, DB01106, NCGC00179240-01, NCGC00179240-02, 4-Piperidinecarboxylic acid, 1-(4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-, (3S-(1(cis),3alpha,4beta))-, HY-14277, AB00514704, CS-0002969, D08117, R50547, AB00514704-06, EN300-6481353, Q2240116, BRD-K33453211-003-03-2, Q27164305, (+-)-trans-1-(cis-4-Cyano-4-(p-fluorophenyl)cyclohexyl)-3-methyl-4-phenylisonipecotic acid, (+-)-trans-1-(cis-4-Cyano-4-(p-fluorophenyl)cyclohexyl)-3-methyl-4-phenylisonipecotic acid., (+/-)-TRANS-1-(CIS-4-CYANO-4-(P-FLUOROPHENYL)CYCLOHEXYL)-3-METHYL-4-PHENYLISONIPECOTIC ACID, (3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-4-piperidinecarboxylic acid, (3S,4R)-3-methyl-4-phenyl-1-[(1s,4s)-4-cyano-4-(4-fluorophenyl)cyclohexyl]piperidine-4-carboxylic acid, 4-PIPERIDINECARBOXYLIC ACID, 1-(4-CYANO-4-(4-FLUOROPHENYL)CYCLOHEXYL)-3-METHYL-4-PHENYL-, (-)-(1(CIS),3.ALPHA.,4.BETA.)-, rel-(3R,4S)-1-[cis-4-Cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-4-piperidinecarboxylic acid

Pubchem:PUBCHEM:54385

Id:26994ed8-1f54-574d-bda8-19af0bda5307

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View levocabastine's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for levocabastine.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with levocabastine.

Results found

Linked to

	Label	Description
	BRD-K33453211-003-11-5 Substance (Entity type)	A Substance
	DCSTRUCT ID 01564 Collection (Entity type)	DrugPage Collection: (DrugCentralID:01564; PubChem_CID:54385, FILE=drugcentral_drug_01564.json)
	levocabastine (0869cd85-8da8-445d-810d-0ca04383be8f) Collection (Entity type)	Metadatata for levocabastine
	levocabastine in similarity relationship with SID11114136 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	levocabastine positively regulates PROM1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	levocabastine negatively regulates SERPINA5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	levocabastine negatively regulates SYBU Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	levocabastine negatively regulates SFTPC Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	levocabastine negatively regulates ADIRF Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	levocabastine negatively regulates RNASE1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS